4//SEC Filing
Actinium Pharmaceuticals, Inc. 4
Accession 0001213900-13-007392
$ATNMCIK 0001388320operating
Filed
Dec 23, 7:00 PM ET
Accepted
Dec 24, 3:37 PM ET
Size
5.5 KB
Accession
0001213900-13-007392
Insider Transaction Report
Form 4
DAVE KAUSHIK J
DirectorPresident and CEO
Transactions
- Award
Options to purchase common stock
2013-12-16$6.70/sh+675,000$4,522,500→ 675,000 totalExercise: $6.70Exp: 2023-12-16→ Common stock (675,000 underlying)
Footnotes (1)
- [F1]Options granted on December 16, 2013 to purchase an aggregate of 675,000 shares of common stock. A total of 28% of the options will vest one year from the grant date, and 2% per month thereafter. As of the date of this report, no options have vested.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388320
Filing Metadata
- Form type
- 4
- Filed
- Dec 23, 7:00 PM ET
- Accepted
- Dec 24, 3:37 PM ET
- Size
- 5.5 KB